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Glucocorticoid and thyroid hormones exert their ef- 
fects in many body tissues by binding to their re- 
spective receptors. The search for possible cross- 
talking mechanisms in overlapping target cells led 
to the discovery of synergism between a thyroid 
hormone receptor-binding site and a cryptic gluco- 
corticoid-responsive element. Glucocorticoid re- 
sponsiveness could only be detected in the pres- 
ence of thyroid hormone and its receptor. This syn- 
ergism requires the glucocorticoid receptor (GR) 
DNA-binding domain and is mediated by the trans- 
activation domains. We found that synergism also 
occurs when the thyroid hormone receptor is re- 
placed by the retinoic acid receptor or the GR is 
replaced by the progesterone receptor. Synergism 
is qualitatively independent of the type of thyroid 
hormone receptor-binding site and promoter. In sev- 
eral combinations of promoter and response ele- 
ments, including a retinoic acid response element, 
T3 induction was only seen in the presence of the 
cryptic glucocorticoid-responsive element, GR, and 
glucocorticoids. (Molecular Endocrinology 8: 440- 
447,1994) 
including synergism between neighboring DNA-bound 
factors (8-l 5). 
Our results demonstrate that the simultaneous pres- 
ence of GR and TR in the nucleus results in synergism 
between the two receptors, thereby changing the re- 
sponse specificity of a target gene. A reporter gene 
regulated by a TR-binding site (T3RE) confers glucocor- 
ticoid responsiveness in addition to and dependent on 
a thyroid hormone response. The glucocorticoid action 
is mediated by a cryptic glucocorticoid-responsive ele- 
ment (GRE), which is nonfunctional unless tested in 
conjunction with a canonical T3RE. 
RESULTS 
Functional Responsive Elements Reveal the 
Presence of a Cryptic GRE 
INTRODUCTION 
Almost all mammalian tissues respond to glucocorti- 
coids. This glucocorticoid effect is mediated by gluco- 
corticoid receptor (GR), which binds to a large set of 
target genes and thereby acts as a ligand-inducible 
transcription factor (l-3). Similarly, thyroid hormones 
bind to thyroid hormone receptor (TR), influencing de- 
velopment and general metabolism in nearly every cell 
type by regulating specific genes (2, 4, 5). Except for 
the subcellular location of both ligand-free receptors 
(TR in the nucleus and GR in the cytoplasm), both 
function similarly, and both have homologous structures 
(6,7). Therefore, we wondered whether GR and TR act 
independently from each other or whether there might 
be some kind of communication between both recep- 
tors. Possible “cross-talking” mechanisms have been 
shown for a limited number of transcription factors, 
To study the combined gene regulation of GR and TR, 
we cotransfected expression vectors coding for the rat 
TRtv and the human GRLu. Their effect on gene regula- 
tion with or without the corresponding ligands was 
determined using a reporter gene consisting of the 
thymidine kinase (tk) promoter and the chloramphenicol 
acetyltransferase (CAT) gene. Binding sites for the 
receptors were inserted in front of the tk promoter (see 
Fig. 2C). Transfections were performed using the hu- 
man mammary carcinoma cell line T47D, which is ca- 
pable of eliciting high hormonal responses. 
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Expression of the tkCAT gene construct containing 
the chicken lysozyme T3RE (GREc-T,RElys-tkCAT; see 
below) was induced g-fold by the addition of T3 hormone 
(Fig. la) in the presence of rat (r) TRcv and human (h) 
GRcu. In contrast, the addition of dexamethasone (dex) 
alone had no effect. The combination of both hormones 
resulted in a very high (go-fold) induction of transcrip- 
tion, suggesting a synergistic action between the two 
hormone receptors. Detailed sequence analysis of the 
reporter plasmid revealed the presence of an element 
resembling a GRE (see also Fig. 2C) located 265 ba- 
sepairs (bp) up-stream of the T,RElys. Binding assays 
using a consensus palindromic GRE, the 38-bp Neil 
fragment containing the GRE-like element, or various 
other vector fragments as competitors demonstrated 
GR binding to the Neil fragment (see also Fig. 2). We 
termed the element located in this fragment a cryptic 
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Fig. 1. T,RElys Synergizes with a cGRE 
T47D cells were transfer&d with 0.1 pmol hGRa and 0.1 
pmol rTRa expression vector together with 1 pmol of different 
tk-CAT reporter plasmids, as indicated. Hormones were added 
2 h after transfection at the following concentrations: 0.1 PM 
L-T~ and 0.5 PM dex (a synthetic glucocorticoid). Cells were 
harvested after 2 days. CAT activities are expressed as the 
percent CAT conversion, and the so from three independent 
experiments is indicated. For activities higher than 70% CAT 
conversion, the assay was repeated using less cell extract, 
and the value was normalized to the weakly active extracts. 
GRE (GREc), because it is unable to mediate glucocor- 
ticoid responsiveness in the absence of TB hormone. 
Deletion of up-stream sequences including the GREc 
did not abrogate TB inducibility, but abolished the syn- 
ergistic GR effect (Fig. 1 b), indicating that the cryptic 
binding site is required for GR/TR synergism. In fact, 
the addition of dex leads to a weak decrease in TJ 
induction, possibly due to a squelching effect in the 
presence of both hormones. As the ligand-free TR is 
able to repress transcription, we investigated whether 
the observed T3/dex effect is due to stimulation or to a 
release of repression. Therefore, we used a reporter 
plasmid containing a mutation in the T3RE so that the 
T3 receptor cannot bind (GREc-T,REmut-tkCAT; see 
Materials and Methods). The basal level in the absence 
of hormone was similar to that obtained with GREc- 
T,RElys-tkCAT, indicating that this low basal level is 
not due to repression via the T,RElys. Neither the 
separate addition of each hormone nor the combination 
of both hormones resulted in a detectable induction of 
GREc-T3REmut-tkCAT (Fig. 1 c), stressing the absolute 
requirement of the T3RE for the observed effects. 
Our data indicate a synergistic effect between 
T,RElys and GREc. The synergism requires both bind- 
ing sites, although the GREc is nonfunctional when 
tested alone. 
The relative orientation of the two receptors or the 
distance between the binding sites is not crucial for the 
synergistic effect. A reporter construct (GREc+4- 
T,RElys-tkCAT) containing a 4-bp insertion, i.e. about 
half a helical turn, between GREc and T,RElys dis- 
played the same inducibility as the original construct 
(Fig. Id). This result suggests that a strict spatial ar- 
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Fig. 2. GREc Weakly Binds the DBD of the GR 
Bacterially expressed GR-DBD is incubated with the indi- 
cated DNA probes, and the complexes formed are analyzed 
on a 5% native polyacrylamide gel electrophoresis. A, A GRE- 
pal (lanes l-3) or GREc (lanes 4-6) probe was incubated in 
the presence of 0.4 or 4 pg bacterial extracts, respectively. In 
lanes 1 and 4, extracts from bacteria nontransformed with 
expression vector but induced with IPTG were used. Lanes 2 
and 5 show the results obtained using transformed but non- 
induced bacterial extracts. Lanes 3 and 6 show the complexes 
formed using GR-DBDcontaining extracts. B, A 1 O-fold longer 
exposure of the gel is shown, displaying lane 6 from A (lane 
1) and the results obtained after incubation of a GAL-4 DNA- 
binding site containing probe with 4 rg extracts from nontrans- 
formed (lane 2) noninduced (lane 3) and transformed plus 
induced bacteria (lane 4). C, Schematic representation of the 
reporter plasmid GREc-T3RElys-tkCAT. Boxes represent the 
tkCAT gene with its transcriptional start site (+l); the relative 
positions of the regular response element (TRE and RARE) 
and the GREc are indicated. The bottom shows a sequence 
comparison of GREc with the canonical GREpal and a con- 
sensus negative GRE (nGRE). 
rangement of the GR or TR is not required for GR/TR 
synergism. 
Cryptic GRE Weakly Binds the Receptor 
To ensure that the cryptic GRE is able to bind GR, we 
performed gel retardation experiments. As the GREc is 
unable to mediate GR inducibility on its own, and the 
homology to known GREs is less than 60% (Fig. 2C), 
we expected the binding to be weak compared to that 
of a consensus palindromic GRE. Therefore, we used 
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the bacterially expressed DNA-binding domain (GR- 
DBD; amino acids 370-503) of hGR, which is present 
in large amounts in crude bacterial extracts. This protein 
contains the zinc finger domain of the GR, which is 
sufficient for specific GRE binding of the receptor (16- 
19). Incubation of extracts containing GR-DBD with a 
labeled GREpal probe led to the formation of a protein- 
DNA complex (Fig. 2A, lane 3). This complex is specific 
for the expressed GR-DBD, as neither extracts from 
nontransformed bacteria nor extracts from transformed 
bacteria in the absence of inducer (IPTG) produced a 
similar complex (Fig. 2, lanes 1 and 2, respectively). 
Similarly, a specific complex was formed using a GREc 
probe and the GR-DBD-containing extracts (lane 6) but 
not with control extracts (lanes 4 and 5). As expected, 
this complex was much weaker than that obtained with 
GREpal. Densitometric scanning analysis of the auto- 
radiograms revealed roughly a 400- to 500-fold lower 
affinity of the GR-DBD for GREc compared to GREpal. 
It should be stressed that for GREpal, the amount of 
protein extract used was lo-fold less than that for 
GREc. The complexes shown are not due to nonspe- 
cific DNA binding of the GR-DBD, as incubation of the 
same extracts with an unrelated DNA sequence con- 
taining a GAL-4-binding site did not give rise to any 
complex, even after a lo-fold longer exposure of the 
gel (Fig. 28, lanes 2-4). 
Taken together, these results show that the GREc 
sequence at position -265 is able to bind the GR 
weakly. Interestingly, the complex formed with GREc 
migrates faster in the gel than the GREpal complex, 
despite the fact that the probe is somewhat longer, 
suggesting.a different arrangement of the GR on this 
weak binding site. 
Synergism Depends on the Transactivation 
Function of the GR and Requires the DBD of the 
Receptor 
We wanted to localize the GR domains required for 
synergism. In the first set of transfection experiments, 
mutants of the GR were cotransfected with 0.1 pmol 
TR expression plasmid. Their ability to synergize with 
TR (fold synergism) was compared to their transacti- 
vation capacity (fold induction), determined by cotrans- 
fecting the mutants with the reporter GREc-(GRE- 
pal)xBtkCAT (18) containing a highly inducible gluco- 
corticoid-responsive unit. The hormone-binding domain 
of the GR was deleted (Fig. 4) generating constitutively 
active transcription factors (17). Thus, the addition of 
dex can be avoided, and possible effects of the endog- 
enous GR can be excluded. Synergism was measured 
by comparing the T,-induced CAT values without and 
with cotransfection of the GR mutants. As demon- 
strated in Fig. 3A, deletion of the hormone-binding 
domain results in proteins functional in synergism. Dele- 
tion of the 72 transactivating domain (hGR 1-515) 
reduces both transactivation and synergism. Deletion 
of ~1 in hGR 262-550 and hGR 262-515 results in 
similar activities as the 72 deletion, although the ~1 
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Fig. 3. Synergism Requires the DBD and Transactivation 
Function of the GR 
Several GR mutants are tested for synergism with TR and 
for transactivation function on a hormone-responsive unit con- 
sisting of several GREs. A, The regions of hGRa retained in 
the mutants are shown on the left. Gal l-l 47 represents the 
DBD of the yeast transcription factor GAL-4. In the center 
table, fold induction indicates transactivation mediated by the 
corresponding mutant compared to the basal activity of the 
reporter plasmid GREc-(GREpal)x2-tkCAT without expression 
of a transactivator. Fold synergism indicates transactivation 
mediated by the corresponding mutant coexpressed with rTRa 
compared to T3 induction of the reporter plasmid GREc- 
T3RElys-tkCAT with rTRa expressed alone. In the right panel, 
open columns indicate the percent transactivation of the GR 
mutants relative to that of the wild-type receptor in the pres- 
ence of hormone. Dark columns indicate fold synergism, as 
explained. B, CAT assays showing transactivation on the 
GREc-GRE-tkCAT reporter plasmid (/et? panel) and synergism 
on GREc-T,RElys-tkCAT (right panel) mediated by mutants 
l-550, 1-550/G441, and the nonrelated GAL-4 expression 
vector. Mutant l-550/G441 was tested in the presence of TR 
expression vector and TS. 
deletion more strongly affected transactivation (1 OO- 
fold, compare l-51 5 to 262-515) than the deletion of 
72 (lo-fold; compare l-550 to 1-515 or 262-550 to 
262-515). The GR/TR synergism mediated by GR mu- 
tants containing only one transactivation domain was 
similarly low. When the complete DBD of the GR mu- 
tants was replaced by that of the yeast transcription 
factor GAL4, the resulting fusion protein completely lost 
its synergizing capability (Fig. 3A). To assess more 
specifically the role of the GR DNA-binding function, a 
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DNA binding-deficient mutant was tested. Mutant l- 
550/G441 carries a deletion of the hormone-binding 
domain and a C to G conversion at position 441 located 
in the first zinc finger, which completely abolishes the 
DNA-binding ability (17). Figure 38 shows that this 
mutant is unable to mediate both transactivation and 
synergism with TR, in contrast to the constitutive activ- 
ity of mutant l-550. 
These data show that transactivation and synergism 
with TR mediated by GR require the same GR domains. 
On the other hand, the absolute requirement for the 
DBD of GR agrees with the involvement of the cryptic 
binding site GREc. 
Progesterone and Retinoic Acid (RA) Receptor 
(RAR) Can Replace GR or TR, Respectively 
To assess the general validity of the observed syner- 
gism, we first tested whether the participating hormone 
receptors can be replaced by other members of the 
steroid receptor superfamily. First we asked whether 
the progesterone receptor (PR), which normally dis- 
plays the same binding specificity as the GR, would be 
able to synergize with TR. The data presented in Fig. 
4a show that the GR can functionally be replaced by 



















Fig. 4. Synergism Is Observed between Other Members of 
the Steroid-TR Family 
A, One picomole of GREc-T,RElys-tkCAT was cotrans- 
fected with 0.1 pmol rTRa expression plasmid. The endoge- 
nous PR was induced by the addition of 0.01 FM R5020 
(synthetic progestin), and the TR by 0.1 PM TB, as indicated. 
8, Cotransfection of 0.1 pmol expression plasmids for hRARn 
and hGRa with 1 pmol of the reporter plasmid GREc-DR5- 
tkCAT hGR was induced by 0.5 KM dex; that of RAR was 
induced by 1 FM RA, as indicated. 
progestin R5020 at 0.01 PM) to reproduce the synergis- 
tic effect. Thus, like the GR, the PR is unable to mediate 
induction via the GREc alone, but strongly synergizes 
with the T,-activated TR. Additionally, a reporter plas- 
mid containing a naturally occurring RA response ele- 
ment (RARE), DR5 (20, 21) was used to test whether 
the hRARcv (22) is able to substitute for TR in synergism 
with GR. Cotransfection of GR and hRARa expression 
vectors with GREc-DR5-tkCAT produced a 30-fold in- 
duction of transcription by RA alone (Fig. 4b). The 
addition of both ligands, dex and RA, led to a 3-fold 
increase in induction. 
Several Different TREs Are Able to Mediate 
Synergism 
In the next set of experiments we investigated whether 
the synergistic response obtained by the combined 
action of TR and GR is restricted to the inverted palin- 
dromic structure of the chicken lysozyme T3RE. Thus, 
we compared the different TR-binding sequences 
T,RElys, T,REpal (23) T,RElap (24) and the direct 
repeat DR4 (20, 21) for their ability to confer synergism 
in combination with TR and GR (0.1 pmol rTRcv and 0.1 
pmol hGRcu). The results shown in Fig. 5 clearly dem- 
onstrate that the orientation of the palindromic T3RE 
half-sites does not play a major role, resulting in only a 
marginal quantitative difference. The high transcrip- 
tional activity of GREc-DRCtkCAT in the presence of 
both hormones probably results from the already high 
T3 response of this construct. 
Different Promoters Respond to GR-TR Synergism 
To test whether the HSV-tk promoter sequences are 
required for the GR/TR synergistic response, we con- 
20 






Fig. 5. Synergism Conferred by Several Different T,REs 
Cotransfection of different reporter plasmids [GREc- 
T3RElys-, GREc-TaREpal-, GREc TaRElap-tk-CAT (24) and 
GREc-DR4-tkCAT with the indicated expression plasmids 
were carried out (see Fig. 1). 
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strutted a set of four additional reporter plasmids. The 
tk promoter sequences were replaced by two other 
viral core promoters [simian virus-40 (SV40) early and 
adenovirus major late promoters], by the basal pro- 
moter of the human cY-globin gene, or by the human 
metallothionein-II gene (Fig. 6A). The chicken lysozyme 
T$tE was inserted in the SalI site of the polylinker, and 
all constructs were tested for synergism using identical 
conditions (0.1 pmol rTRa and 0.1 pmol hGRa). The 
results from this set of transfection experiments are 
presented in Fig. 6B. All promoters produced a syner- 
gistic response, extending the general validity of GR/ 
TR synergism. These experiments demonstrate the 
difference in the magnitude between single induction 
and synergism. Two of the T3RE promoter combina- 
tions tested (GREc-T,RElys-glob-CAT and GREc- 
T,RElys-adeno-CAT) did not respond to the addition of 
thyroid hormone or dex, respectively. Only the com- 
bined administration of both hormones resulted in an 
induction of approximately 250-fold, in contrast to the 
about 28fold synergistic induction (T3 vs. dex plus T3) 
observed for the three other promoters. This result 
defines a new type of glucocorticoid-responsive unit: 
A 
Ik-cAT 
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Fig. 6. Promoter-Specific Responsiveness to Synergism 
Cotransfection of rTRa and hG& expression plasmids with 
various reporter constructs. The reporter constructs are de- 
picted in A; the position of the inserted TaRElys fragment is 
indicated by a triangle. B, CAT activities of transfection exper- 
iments. Hormone additions are explained in the inset. The 
lower part of the figure is magnified so as that any small effects 
by individual hormones can be seen. 
T3RE containing promoters insensitive to TB induction 
functionally respond to glucocorticoids in the presence 
of TB and a cryptic GRE. 
Synergism Occurs in Different Cell Lines 
To test whether the synergism between GR and TR is 
a cell-specific effect, the reporter plasmid GREc-T,RE- 
glob-CAT was transfected together with expression 
plasmids for TR and GR into additional cell lines. In 
MCF-7 cells, a human mammary carcinoma line, a 
strong synergism was seen compared to the basal level 
obtained with single hormone addition, although CAT 
activity in the presence of both hormones was lower 
than that in T47D cells (Fig. 7). In CVl cells, the CAT 
activity was much lower, but a clear TB induction, 
depending on the presence of dex, was detected. 
Synergism Alters the Specificity of Responsive 
Elements 
As shown in Fig. 8a, the RA-induced activation of the 
RAR on a DR5, a naturally occurring RARE, containing 
reporter plasmid could be increased 3-fold by simulta- 
neous addition of Dex. We were interested in the effect 
of TR on such a reporter plasmid. It had been shown 
that TR is able to bind to a DR5 element, but cannot 
transactivate this RARE (20, 21). We cotransfected a 





Reporter: GREc T3RElys glob-CAT 
Fig. 7. Synergism Is Detected in Different Cell Lines 
GREc-T,RElys-globCAT was transfected into T47D, MCF- 
7, and CVl cells along with expression vectors for GR and 
TR. CAT conversion in the presence of the indicated hormones 
is shown. 











Fig. 8. The Specificity of a Hormone Response Element Can 
Be Changed by Synergism 
A, Cotransfection of 1 pmol GREc-DRS-tkCAT with 0.1 pmol 
hRARa and 0.1 pmol hGRa expression plasmid. B, Cotrans- 
fection of 1 pmol GREc-DRS-tkCAT with 0.1 pmol rTRa and 
0.1 pmol hGRa expression plasmid. Induction with hormone 
was performed as described in Fig. 4. 
GREc-DR5-tk-CAT reporter plasmid with expression 
plasmids for rTRa and hGRa: (Fig. 8b). As expected, no 
TI induction could be seen. The addition of glucocorti- 
coids alone could not activate transcription, as shown 
in all previous cases. Induction of both receptors re- 
sulted in the activation of transcription comparable to 
that of the RAR shown in Fig. 8a. 
By the synergistic action of two receptors, which 
alone are unable to activate this gene, the specificity of 
the RARE is overruled, and TR can mediate activation 
through this element in the presence of GR. 
DISCUSSION 
The effects of steroids and thyroid hormones on devel- 
opment, differentiation, and gene regulation have been 
intensively studied. Thyroid hormones and the gluco- 
corticoid cortisol were the first hormones to be purified 
and characterized. In fact, most body tissues respond 
to these hormones. Therefore, the simultaneous action 
conferred by the receptors for both hormones is the 
rule rather than an exception. 
Here we show that the presence of a cryptic GRE is 
able to mediate a strong synergism between TR and 
GR. Several lines of evidence illustrate the requirement 
for specific DNA binding of GR in synergism. Changing 
the DNA binding specificity of the GR by switching to 
the GAL4 DBD or destroying the DNA binding of the 
GR by a point mutation abolished the effect. Deletion 
of the GREc in the CAT vector resulted in a loss of 
synergistic activation. Finally, we could show that this 
DNA element binds the GR in vitro, although with a 
very low affinity. It is unclear whether the slightly differ- 
ent electrophoretic mobility of the GR/GREc complex 
compared to that of the GR/GREpal reflects a different 
binding geometry of the receptor to these elements, as 
was described for a negative GRE in the POMC gene 
(25). Very importantly, the presence of the GREc could 
only be functionally detected in the presence of a con- 
sensus receptor-binding site, a TBRE or RARE. This 
underscores the importance of weak binding sites that 
show strong activities in the presence of other ele- 
ments, in our case mediating a thyroid hormone-de- 
pendent glucocorticoid induction. 
We believe that the phenomenon of synergism ex- 
plains the cooperative effect of the two hormones seen 
in several cases. For example, the rat phosphoenolpy- 
ruvate carboxykinase gene requires both hormones for 
induction (26). Furthermore, synergism may explain 
how T3 induction of the GH gene can be potentiated by 
glucocorticoids. Either TB or RA is required to mediate 
glucocorticoid induction of the GH gene (27, 28). Mul- 
tiple T,REs have been found in the rat GH gene (29) 
whereas a GRE has not been identified. Also, the 
concentration of TR is not changed by glucocorticoid 
induction (30). Thus, GH induction may be mediated by 
synergism of a cryptic GRE with the T3RE sequences. 
In addition to increasing the T3 stimulus, synergism 
increases the number of GR-inducible genes, as TB- 
inducible genes containing cryptic GREs may be induc- 
ible by glucocorticoids as well. This effect is very striking 
for promoters that contain a T3RE but are minimally T3 
responsive, as we have demonstrated in two cases. In 
addition, we showed that an otherwise unresponsive 
TR-binding site (DR5), which is a specific RA-respon- 
sive element, is turned to a thyroid hormone-responsive 
element in the presence of GREc. These observations 
suggest that the response pattern of a gene to various 
stimuli is influenced by very weak binding sites for some 
transcription factors. 
An additional complexity can be introduced by the 
apparent cell specificity of GR/TR synergism. Although 
the effect is seen in different cell lines, it is much 
stronger in the mammary tumor cell lines T47D and 
MCF-7. It is unclear whether this observation is due to 
the generally more active transcription machinery in 
these cell lines or whether it might be related to the 
mammary carcinoma1 origin of the cells. 
Possible interplays between identical or different sig- 
nal transduction pathways have been demonstrated 
between nuclear receptors and nonreceptor transcrip- 
tion factors binding to adjacent sites (1, 3, 13, 14). 
Depending on the factors involved, different domains of 
the GR are required for synergism: the DBD (18) the 
transactivating domain, or the steroid-binding domain 
(31). Analysis of GR deletion mutants revealed that the 
transactivating domains are required for synergism with 
TR mediated by GREc. The hormone-binding domain 
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is not involved, in contrast to the previously described 
synergism of a consensus GRE with a CACCC box 
(31). 
MATERIALS AND METHODS 
Plasmids 
Expression vectors for the different receptors were kindly 
provided by R. Evans (16, 22, 32). Expression vectors for GR 
mutants have been previously described (17, 31) as well as 
the vector for GAL-GR and the bacterial expression vector for 
GR DBD (19). Previously described reporter plasmids contain 
the vector-based GREc and were, therefore, renamed. GREc- 
TJRElys-tkCAT, GREc-T3REmut-tkCAT, GREc-T,REpal- 
tkCAT, and GREc-T,RElap-tkCAT correspond, respectively, 
to F2-, TREmut-, TREpal-, and TRElap-tkCAT in Ref. 24. 
GREc-(GREpal)x2-tkCAT and GREc-GRE-tkCAT were de- 
scribed previously (14, 18) as pGpal 29 Gpal tkCAT and p G 
29 C’tkCAT, respectively. GREc-DRCtkCAT and GREc-DR5- 
tkCAT contain, respectively, the oligonucleotides 5’-TCGA- 
AGCTTGACCTCCTGCTGTGACCTGAAGCT-3’ and 5’-TCG- 
AAGCTCAGGTCACCAGGAGGTCAAGCT-3’ cloned into the 
SalI site of ptkCATAH/N (24). T,RElys-tkCAT was obtained 
bv deletinq the EcoOl OS/Hindlll fragment from GREc-T,RElys- 
&CAT. GREc+4-T,RElys-tkCAT was generated by a Hindlll 
diaest. followed bv Klenow fill-in and reliqation of GREc- 
T&El&tkCAT. The CAT reporter plasmids harboring different 
core promoter sequences in front of the CAT-coding region 
were constructed as follows (compare Fiq. 7). The SV40 core 
promoter sequences were isolated as a ?/indlll (filled-in)/Bg/ll 
fragment from pA1 OCAT2 (33) and inserted into the Xhol (filled- 
in)/Bglll sites of pBLCAT2 (34). The promoter sequences, 
including a part of the polyiinker. were excised as a Hindlll 
(filled-in)/fstl fragment and reinserted into the BarnHI (filled- 
in)/Pstl sites of pBLCAT3. Finally, transactivating up-stream 
vector sequences (pUC18) were removed by a Hindlll/Ndel 
deletion to generate SV40 core CAT. The plasmid hMT-IIA- 
CAT was constructed by ligation of the Hindlll (filled-in)/Bg/ll 
metallothionein promoter fragment of MCAT2 (gift from P. 
Mitchel and R. Tjian), a Hindlll/Bg/ll polylinker fragment of 
pBLCAT3, and the vector ptkCATAH/N (24) from which the 
HSV-tk promoter was deleted by Erg/II (filled-in)/Hindlll diges- 
tion The construct ha-globin-CAT was made by replacing the 
HSV-tk promoter of ptkCATAH/N (BarnHI (filled-in)/Bg/ll (filled- 
in)) by the Xmal (filled-in)/Ncol (filled-in) promoter fragment of 
the piasmid pa-gfobin (gift from B. Ondek and W. Herr). In the 
reoorter olasmid adenoML-CAT the HSV-tk promoter of the 
parental CAT construct ptkCATAH/N was replaced by a syn- 
thetic oligonucleotide comprising the adenovirus major late 
promoter sequences (35) from -53 to 41 bp plus half of the 
BamHl and Xhol restriction sites. The correct sequences were 
verified by sequencing. Derivatives of the CAT constructs 
described above, containing in addition the chicken lysozyme 
thyroid response element T,RElys (F2) (24) were generated 
by replacing the Hindlll/BamHI polylinker of the respective 
parental plasmids by the Hindlll/BamHI polylinker fragment of 
F2tkCAT. In this fragment, the lysozyme T,RE is located in 
the filled-in SalI site. 
Cell Culture, DNA Transfections, and CAT Assays 
T47D and MCF-7 cells were grown and transfected by the 
diethylaminoethyl-dextran method, as described previously 
(36). CVl cells were transfected by the CaP04 method, as 
previously described (36). For hormonal induction experiments 
the serum was depleted of steroids, thyroid hormone, and RA 
as previously described (37) and by charcoal stripping. CAT 
assays were performed as previously described (38) with 
minor modifications (36). All cells were harvested 2 days after 
transfection. Diagnostic cotransfections with a control plasmid 
showed the reproducibility of the transfections. Therefore, the 
CAT activities achieved did not have to be corrected, rather 
the mean and SD from independent triplicate experiments are 
presented. 
Bacterial Extracts and Gel Retardation 
Extracts were made from bacteria transformed with an expres- 
sion vector coding for the hGRa DBD (residues 370-502). 
After induction of expression by the addition of 0.5 mM isopro- 
pyl-fl-o-thiogalactopyranoside, bacteria were processed as 
previously described (18. 19). Gel retardation experiments 
were performed (18). The probes were obtained as follows. 
GREc was a Neil fragment spanning nucleotides 49-84 from 
GREc-TsRElys-tkCAT. GREpal was a Hindlll/Xbal fragment 
from GREc-(GREpal)x2-tkCAT. Both were purified by poly- 
acrylamide gel electrophoresis and eluted from the gel. The 
UAS probe was a synthetic oligonucleotide previously de- 
scribed (18). The probes were “P labeled using polynucleotide 
kinase. 
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